评估了87例脑转移瘤再放疗的图像配准效果,发现现有方法仍不够可靠。
Is Deformable Image Registration Ready for Brain Metastasis Reirradiation Dose Accumulation? A Longitudinal MRI Benchmark of Registration Accuracy

- 对比学习型与优化型配准方法在纵向MRI上的表现
- 优化后学习模型性能提升,但整体仍不如传统优化方法
- 强调临床应用需逐例质量控制和剂量影响评估
剂量累积在自适应放疗和再放疗中日益重要,其临床有效性依赖于可变形图像配准(DIR)的性能。脑转移瘤(BMs)的立体定向放射外科(SRS)再治疗提供了一个受控但具临床意义的DIR测试案例:在刚性对齐后,个体脑部形变通常有限,但复发病灶可能经历显著的局部形态与体积变化,刚性配准无法捕捉,影响剂量累积。本研究在机构内87例经人工筛选的纵向增强T1加权MRI病灶对上,基准测试了多种基于学习和优化的DIR方法。基于学习的方法在健康脑部MRI预训练后进行零样本测试,并通过实例特定优化(ISO)或肿瘤邻近目标特定优化(TSO)微调。配准性能通过病灶重叠(Dice)、表面距离指标(HD95和sASD)、靶区体积恢复率以及运行时间和内存消耗评估。预训练学习方法在零样本下表现不一,而ISO/TSO提升了所有学习类方法的性能。然而,优化类方法在保持合理运行时间的同时仍是最佳表现者。这些发现表明,即使是最先进的DIR方法,尚未足够准确且一致,无法在无监督情况下用于脑转移瘤再放疗剂量累积。由于准确配准是可变形剂量累积的前提,临床应用需逐病例质量控制,并直接评估配准不确定性对下游剂量指标的影响。
原文摘要 · Abstract (English)
Dose accumulation is increasingly important in adaptive radiation therapy and reirradiation, but its clinical validity depends on the performance of deformable image registration (DIR). Reirradiation of brain metastases (BMs) with stereotactic radiosurgery (SRS) provides a controlled but clinically meaningful DIR test case: intra-subject brain deformation is usually limited after rigid alignment, yet recurrent lesions can undergo substantial local shape and volume changes that rigid registration cannot capture and can affect dose accumulation. We benchmarked a wide range of learning-based and optimization-based DIR methods on 87 manually screened longitudinal contrast-enhanced T1-weighted MRI lesion pairs from an institutional BM SRS retreatment cohort. Learning-based methods pretrained on healthy-brain MRI were evaluated zero-shot and after instance-specific optimization (ISO) or tumor-proximity target-specific optimization (TSO). Registration was assessed using lesion overlap (Dice), surface distance metrics (HD95 and sASD), target-volume recovery, and runtime and memory. Pretrained learning-based methods showed variable zero-shot performance, while ISO/TSO improved all tested learning-based families. However, optimization-based methods remained the best-performing approach while maintaining reasonable runtime. These findings suggest that even state-of-the-art DIR methods do not yet provide sufficiently accurate and consistent registration for unmonitored use in brain metastasis reirradiation dose accumulation. Because accurate registration is a prerequisite for deformable dose accumulation, clinical application will require case-level quality control and direct assessment of how registration uncertainty affects downstream dose metrics.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。